INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS

This adverse event was reported 3066 times

These drugs are most commonly taken by patients reporting INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS:

# Drug Count
0 DORNASE ALFA 1578
1 LUMACAFTOR AND IVACAFTOR 1268
2 PANCRELIPASE 1163
3 TOBRAMYCIN 1122
4 TEZACAFTOR AND IVACAFTOR 934
5 ALBUTEROL SULFATE 763
6 SODIUM CHLORIDE 493
7 ERGOCALCIFEROL 468
8 ALBUTEROL 437
9 FLUTICASONE PROPIONATE 418
See all common drugs associated with INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS

INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TEZACAFTOR AND IVACAFTOR 934 0.2221
1 FLUTICASONE PROPIONATE (GLUCOCORTICOID) 2 0.2000
2 LUMACAFTOR AND IVACAFTOR 1268 0.1884
3 DORNASE ALFA 1578 0.1493
4 LIDOCAINE 2.5% AND PRILOCAINE 2.5% 1 0.1111
5 COLISTIMETHATE SODIUM 43 0.0945
6 TOBRAMYCIN 1122 0.0866
7 LEVALBUTEROL INHALATION SOLUTION 1 0.0833
8 LACTOBACILLUS RHAMNOSUS 15 0.0815
9 TOBRAMYCIN SULFATE 398 0.0770
See all drugs enriched for association with INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS

These drug classes are most commonly taken by patients reporting INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS:

# Drug class Count
0 Insulin Analog [EPC] 145
1 Tetracycline-class Drug [EPC] 87
2 Stimulant Laxative [EPC] 3
3 Angiotensin Converting Enzyme Inhibitor [EPC] 2
See all common drug classes associated with INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS

INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Tetracycline-class Drug [EPC] 87 0.0029
1 Insulin Analog [EPC] 145 0.0014
2 Stimulant Laxative [EPC] 3 0.0003
3 Angiotensin Converting Enzyme Inhibitor [EPC] 2 0.0000
See all drug classes enriched for association with INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS